BioSpace News Archive

Pluton Biosciences, a startup leveraging the power of microbes to create cost-effective innovative solutions that address sustainability challenges facing agriculture, announces the close of a $16.5 M Series A funding round.

Scientists at Klick Labs have developed a new way to catch the earliest signs the human body is failing to control blood glucose levels, before it reaches prediabetic levels in patients.

Prenatal exposure to tobacco, alcohol, and illegal drugs may increase a child’s risk of displaying certain problem behaviors in later childhood, according to new research funded by the Environmental influences on Child Health Outcomes Program (ECHO) at the National Institutes of Health.

Adaptive Biotechnologies Corporation, a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, announced it will be participating in the following investor conferences.

Alpha Tau Medical Ltd., the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced that management will participate in the following investor conferences.

Ocuphire Pharma, Inc., announced that the Compensation Committee of its Board of Directors, which is composed entirely of independent directors, approved an equity award under Ocuphire’s Inducement Plan, as a material inducement to a new hire in connection with such new hire’s employment with the Company effective on May 22, 2023.

Relay Therapeutics, Inc. announced that management will participate in two upcoming fireside chats.

Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced the addition of Folate Receptor Alpha to its Precise™ Oncology Solutions portfolio.

GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, announced that management will participate at the following investor conferences in June.

Revolution Medicines, Inc. announced that Mark A. Goldsmith, M.D., Ph.D., the company’s chief executive officer and chairman, will be a featured speaker in a fireside chat at the TD Cowen 4th Annual Oncology Innovation Summit.